NCT03211611View on ClinicalTrials.gov

Management of Women With BRCA1/2 Mutation

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

August 31, 2017

Study Completion Date

November 1, 2017

Conditions
BRCA1 MutationBRCA2 Mutation
Interventions
BEHAVIORAL

Questionnaire given to the two groups

"Questionnaire given to the two groups :~Patients with BRCA ½ mutation GP"

Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03211611 - Management of Women With BRCA1/2 Mutation | Biotech Hunter | Biotech Hunter